Toxoplasma gondii antibodies in cancer patients

Cancer Letters

Volumn 254, Issue 1, 2007, Pages 71-74

  Yuan, Ziguo ^a   Gao, Shengyan ^a,b   Liu, Quan ^a   Xia, Xianzhu ^a   Liu, Xiaofeng ^c   Liu, Bin ^d   Hu, Rongliang ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b JILIN AGRICULTURAL UNIVERSITY   (China)

^c Changchun Central Hospital   (China)

^d No 208 Hospital of PLA   (China)

Author keywords

Antibody; Nasopharyngeal carcinoma; Rectal cancer; Toxoplasma gondii

Indexed keywords

ANTIBODY; IMMUNOGLOBULIN G;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; BREAST CANCER; CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LIVER CELL CARCINOMA; LUNG CARCINOMA; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; PARASITOSIS; PRIORITY JOURNAL; RECTUM CANCER; SEROLOGY; TOXOPLASMA GONDII; TOXOPLASMOSIS;

ADULT; AGED; ANIMALS; ANTIBODIES, PROTOZOAN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASMS; RECTAL NEOPLASMS; TOXOPLASMA; TOXOPLASMOSIS;

TOXOPLASMA GONDII;

EID: 34447314464     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2007.02.011     Document Type: Article

References (29)

1. Nowakowska D., Stray-Pedersen B., Spiewak E., Sobala W., Malafiej E., and Wilczynski J. Prevalence and estimated incidence of Toxoplasma infection among pregnant women in Poland: a decreasing trend in the younger population. Clin. Microbiol. Infect. 12 (2006) 913-917
2. Jones J.L., Lopez A., Wilson M., Schulkin J., and Gibbs R. Congenital toxoplasmosis: a review. Obstet. Gynecol. Surv. 56 (2001) 296-305
3. Guerina N.G. Congenital infection withToxoplasma gondii. Pediatr. Ann. 23 (1994) 138-142 147-151
4. Dutton G.N. Toxoplasmic retinochoroiditis - a historical review and current concepts. Ann. Acad. Med. Singapore 18 (1989) 214-221
5. Holland G.N. Reconsidering the pathogenesis of ocular toxoplasmosis. Am. J. Ophthalmol. 128 (1999) 502-505
6. Schuman J.S., Orellana J., Friedman A.H., and Teich S.A. Acquired immunodeficiency syndrome (AIDS). Surv. Ophthalmol. 31 (1987) 384-410
7. Vidal J.E., Colombo F.A., de Oliveira A.C., Focaccia R., and Pereira-Chioccola V.L. PCR assay using cerebrospinal fluid for diagnosis of cerebral toxoplasmosis in Brazilian AIDS patients. J. Clin. Microbiol. 42 (2004) 4765-4768
8. Schluter D., Kwok L.Y., and Lutjen S. Both lymphotoxin-alpha and TNF are crucial for control of Toxoplasma gondii in the central nervous system. J. Immunol. 170 (2003) 6172-6182
9. Dubey J.P. Strategies to reduce transmission of Toxoplasma gondii to animals and humans. Vet. Parasitol. 64 (1996) 65-70
10. Luft B.J., Conley F., and Remington J.S. Outbreak of central-nervous-system toxoplasmosis in western Europe and North America. Lancet 1 (1983) 781-784
11. Michel G., Thuret I., Chambost H., Scheiner C., Mary C., and Perrimond H. Lung toxoplasmosis after HLA mismatched bone marrow transplantation. Bone Marrow Transplant. 14 (1994) 455-457
12. Ryan P., Hurley S.F., and Johnson A.M. Tumours of the brain and presence of antibodies to Toxoplasma gondii. Int. J. Epidemiol. 22 (1993) 412-419
13. Dawis M.A., Bottone E.J., Vlachos A., and Burroughs M.H. Unsuspected Toxoplasma gondii empyema in a bone marrow transplant recipient. Clin. Infect. Dis. 34 (2002) 7-9
14. Ruskin J., and Remington J.S. Toxoplasmosis in the compromised host. Ann. Intern. Med. 84 (1976) 193-199
15. Yazar S., Yaman O., Eser B., Altuntas F., Kurnaz F., and Sahin I. Investigation of anti-Toxoplasma gondii antibodies in patients with neoplasia. J. Med. Microbiol. 53 (2004) 1183-1186
16. Urrutia J.J., Sosa R., Kennell J.H., and Klaus M. Prevalence of maternal and neonatal infections in a developing country: possible low-cost preventive measures. Ciba Found. Symp. (1979) 171-186
17. Campagna A.C. Pulmonary toxoplasmosis. Semin. Respir. Infect. 12 (1997) 98-105
18. Hunter C.A., Yu D., and Gee M. Cutting edge: systemic inhibition of angiogenesis underlies resistance to tumors during acute toxoplasmosis. J. Immunol. 166 (2001) 5878-5881
19. Klastersky J. Infections in immunocompromised patients. I. Pathogenesis, etiology, and diagnosis. Clin. Ther. 8 (1985) 90-99
20. Kamiyama T., and Tatsumi M. Effect of Toxoplasma infection on the sensitivity of mouse thymocytes to natural killer cells. Infect. Immun. 42 (1983) 789-795
21. McLeod R., and Estes R.G. Role of lymphocyte blastogenesis to Toxoplasma gondii antigens in containment of chronic, latent T. gondii infection in humans. Clin. Exp. Immunol. 62 (1985) 24-30
22. Peacock J.E., Greven C.M., Cruz J.M., and Hurd D.D. Reactivation toxoplasmic retinochoroiditis in patients undergoing bone marrow transplantation: is there a role for chemoprophylaxis?. Bone Marrow Transplant. 15 (1995) 983-987
23. Dimberg J., Hugander A., and Wagsater D. Protein expression of the chemokine, CCL28, in human colorectal cancer. Int. J. Oncol. 28 (2006) 315-319
24. Ranheim E.A., Jones C., Zehnder J.L., Warnke R., and Yuen A. Spontaneously relapsing clonal, mucosal cytotoxic T-cell lymphoproliferative disorder: case report and review of the literature. Am. J. Surg. Pathol. 24 (2000) 296-301
25. Buzoni-Gatel D., Schulthess J., Menard L.C., and Kasper L.H. Mucosal defences against orally acquired protozoan parasites, emphasis on Toxoplasma gondii infections. Cell Microbiol. 8 (2006) 535-544
26. Kasper L., Courret N., and Darche S. Toxoplasma gondii and mucosal immunity. Int. J. Parasitol. 34 (2004) 401-409
27. McLeod R., Eisenhauer P., Mack D., Brown C., Filice G., and Spitalny G. Immune responses associated with early survival after peroral infection with Toxoplasma gondii. J. Immunol. 142 (1989) 3247-3255
28. ubauste C.S., and Remington J.S. Immunity to Toxoplasma gondii. Curr. Opin. Immunol. 5 (1993) 532-537
29. Tenter A.M., Heckeroth A.R., and Weiss L.M. Toxoplasma gondii: from animals to humans. Int. J. Parasitol. 30 (2000) 1217-1258